USVP Closes Latest Early-Stage Venture Capital Fund, at $340M

U.S. Venture Partners

U.S. Venture Partners (USVP), a Menlo Park, Calif.-based early-stage venture capital firm, closed USVP XII, at $340M.

Led by Steve Krausz, Rick Lewis, Jonathan Root, Casey Tansey, Dafina Toncheva and Jacques Benkoski, the fund continues the firm’s strategy of being the lead Series A investor in companies based in the U.S. or Israel in four core sectors: cybersecurity, enterprise software, consumer and healthcare—including the emerging digital health sector.

The team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development.

USVP has invested in over 400 companies spanning four decades, including: Box, Check Point Software, Guidewire, HeartFlow, HotelTonight, Imperva, Inari Medical, Inspire Medical Systems, Intersect ENT, Luminate, Omada Health, Pluto TV, Prevoty, Sequent, ThreatMetrix, Trunk Club, Trusteer, Vontu, Yammer and Zerto. 

So far, the firm has led investments in 88 companies that completed initial public offerings and 85 more that were profitably acquired.



Join the discussion